Wanbury Limited (WANBURY.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Wanbury Limited
Address
BSEL Tech Park, B-Wing
Navi Mumbai, 400703
India
Phone
91 22 6794 2222
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1491
First IPO Date
January 29, 2007
Key Executives
| Name | Title | Pay | Year Born |
| Pradeep Patni | Chief Executive Officer of India Formulation Business | 0 | 1960 |
| Jitendra J. Gandhi | Compliance Officer & Company Secretary | 3.82M | N/A |
| Vinod R. Verma | Chief Financial Officer | 13.84M | N/A |
| Shireesh Bhalchandra Ambhaikar | President of Operations - API Business | 14.98M | N/A |
| Nanasaheb Gunjal | Senior Vice President of QA,QC & RA | 0 | 1963 |
| Prakash Venkataraman | Head of API Business | 0 | 1966 |
| Mohan Kumar Rayana | Whole Time Director | 0 | 1959 |
Description
Wanbury Limited is an Indian pharmaceutical company engaged in the development, manufacturing, and commercialization of both finished drug products (formulations) and active pharmaceutical ingredients (APIs). The company's diverse range of formulations addresses numerous therapeutic areas, including women's health, bone and joint conditions, hematological disorders, diabetes management, nutritional support, gastrointestinal ailments, post-stroke recovery, infectious diseases, respiratory issues, inflammatory conditions, pain relief, and general medicine, marketed under approximately 70 different brands. Additionally, Wanbury supplies APIs vital for medicines treating diabetes, pain, depression, allergies, inflammation, arthritis, thrombosis, epilepsy, and hypertension. The company extends its reach beyond India through product exports. Originally incorporated in 1988 as Pearl Organics Limited, the firm was rebranded as Wanbury Limited in 2004 and maintains its corporate headquarters in Navi Mumbai, India.
